234 related articles for article (PubMed ID: 16618650)
1. Functional outcome of treatment of Ménière's disease with the Meniett pressure generator.
Stokroos R; Olvink MK; Hendrice N; Kingma H
Acta Otolaryngol; 2006 Mar; 126(3):254-8. PubMed ID: 16618650
[TBL] [Abstract][Full Text] [Related]
2. Meniett therapy: rescue treatment in severe drug-resistant Ménière's disease?
Boudewyns AN; Wuyts FL; Hoppenbrouwers M; Ketelslagers K; Vanspauwen R; Forton G; Van de Heyning PH
Acta Otolaryngol; 2005 Dec; 125(12):1283-9. PubMed ID: 16303675
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
Rajan GP; Din S; Atlas MD
J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
[TBL] [Abstract][Full Text] [Related]
4. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière's disease--a clinical multicentre placebo-controlled study.
Odkvist LM; Arlinger S; Billermark E; Densert B; Lindholm S; Wallqvist J
Acta Otolaryngol Suppl; 2000; 543():99-101. PubMed ID: 10908991
[TBL] [Abstract][Full Text] [Related]
5. Local pressure protocol, including Meniett, in the treatment of Ménière's disease: short-term results during the active stage.
Barbara M; Consagra C; Monini S; Nostro G; Harguindey A; Vestri A; Filipo R
Acta Otolaryngol; 2001 Dec; 121(8):939-44. PubMed ID: 11813899
[TBL] [Abstract][Full Text] [Related]
6. The effect of the Meniett device in patients with Ménière's disease: long-term results.
Dornhoffer JL; King D
Otol Neurotol; 2008 Sep; 29(6):868-74. PubMed ID: 18617868
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of the Meniett device in Japanese patients with Meniere's disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan.
Shojaku H; Watanabe Y; Mineta H; Aoki M; Tsubota M; Watanabe K; Goto F; Shigeno K
Acta Otolaryngol; 2011 Mar; 131(3):277-83. PubMed ID: 21319947
[TBL] [Abstract][Full Text] [Related]
8. Influence of Meniett® treatment on hearing.
Barbara M; Lazzarino AI; Biagini M; Costa M; Monini S
Acta Otolaryngol; 2010 Nov; 130(11):1256-9. PubMed ID: 20446875
[TBL] [Abstract][Full Text] [Related]
9. Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.
Gürkov R; Filipe Mingas LB; Rader T; Louza J; Olzowy B; Krause E
J Laryngol Otol; 2012 Apr; 126(4):356-62. PubMed ID: 22365373
[TBL] [Abstract][Full Text] [Related]
10. Meniett clinical trial: long-term follow-up.
Gates GA; Verrall A; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1311-6. PubMed ID: 17178941
[TBL] [Abstract][Full Text] [Related]
11. Control of symptoms in patients with Meniere's disease using middle ear pressure applications: two years follow-up.
Densert B; Sass K
Acta Otolaryngol; 2001 Jul; 121(5):616-21. PubMed ID: 11583396
[TBL] [Abstract][Full Text] [Related]
12. Intermittent pressure therapy of intractable Meniere's disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report.
Watanabe Y; Shojaku H; Junicho M; Asai M; Fujisaka M; Takakura H; Tsubota M; Yasumura S
Acta Otolaryngol; 2011 Nov; 131(11):1178-86. PubMed ID: 21838607
[TBL] [Abstract][Full Text] [Related]
13. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
[TBL] [Abstract][Full Text] [Related]
14. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.
Gates GA; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15210552
[TBL] [Abstract][Full Text] [Related]
15. Meniett therapy may avoid vestibular neurectomy in disabling Meniere's disease.
Barbara M; Monini S; Chiappini I; Filipo R
Acta Otolaryngol; 2007 Nov; 127(11):1136-41. PubMed ID: 17851896
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and meta-analysis of Meniett therapy for Meniere's disease.
Ahsan SF; Standring R; Wang Y
Laryngoscope; 2015 Jan; 125(1):203-8. PubMed ID: 24913022
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
[TBL] [Abstract][Full Text] [Related]
18. Intermittent pressure therapy of intractable Ménière's disease using the Meniett device: a preliminary report.
Gates GA; Green JD
Laryngoscope; 2002 Aug; 112(8 Pt 1):1489-93. PubMed ID: 12172267
[TBL] [Abstract][Full Text] [Related]
19. [Middle ear overpressure with Meniett in Menière disease: indications, results at short and middle terms in 53 cases].
Faict H; Bouccara D
Rev Laryngol Otol Rhinol (Bord); 2007; 128(1-2):33-6. PubMed ID: 17633662
[TBL] [Abstract][Full Text] [Related]
20. Three new surgeries for treatment of intractable Meniere's disease.
Huang TS
Am J Otol; 1999 Mar; 20(2):233-7. PubMed ID: 10100528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]